IOCAS-IR
(本次检索基于用户作品认领结果)

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 卷号: 222, 页码: 562-572
作者:  Deng, Zhenzhen;  Wu, Ning;  Suo, Qishan;  Wang, Jing;  Yue, Yang;  Geng, Lihua;  Zhang, Quanbin
Adobe PDF(8782Kb)  |  收藏  |  浏览/下载:128/0  |  提交时间:2023/01/04
Capecitabine  Tumor microenvironment  Macrophages  TLR4  Fucoidan  
Low molecular weight fucoidan fraction LF2 improves metabolic syndrome via up-regulating PI3K-AKT-mTOR axis and increasing the abundance of Akkermansia muciniphila in the gut microbiota 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 卷号: 193, 页码: 789-798
作者:  Deng, Zhenzhen;  Wu, Ning;  Wang, Jing;  Geng, Lihua;  Yue, Yang;  Wang, Fahe;  Zhang, Quanbin
Adobe PDF(3607Kb)  |  收藏  |  浏览/下载:173/0  |  提交时间:2022/02/18
Fucoidan  Metabolic syndrome  Gut microbiota  
Comparative Study of Fucoidan from Saccharina japonica and Its Depolymerized Fragment on Adriamycin-Induced Nephrotic Syndrome in Rats 期刊论文
MARINE DRUGS, 2020, 卷号: 18, 期号: 3, 页码: 10
作者:  Tan, Jiaojiao;  Wang, Jing;  Geng, Lihua;  Yue, Yang;  Wu, Ning;  Zhang, Quanbin
Adobe PDF(401Kb)  |  收藏  |  浏览/下载:187/0  |  提交时间:2020/09/23
fucoidan  low-molecular-weight fucoidan  adriamycin  nephrotic syndrome